Skip to main content
PMC home page
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1965;32(1):59–72.

Biochemical laboratory tests in viral hepatitis and other hepatic diseases

Evaluation and follow-up*

Fernando De Ritis, Giuseppe Giusti, Felice Piccinino, Luigi Cacciatore
PMCID: PMC2555202  PMID: 14292063

Abstract

The differential diagnosis between viral hepatitis and other liver diseases (particularly obstructive jaundice) is often difficult on purely clinical grounds. Damage to the liver causes changes in the pattern of the serum enzymes and this has led to the development in recent years of a number of enzyme tests. The authors have amassed evidence to show that the most useful of these is determination of the levels of serum glutamic oxalacetic and serum glutamic pyruvic transaminase (SGOT and SGPT), coupled with calculation of the SGOT/SGPT ratio. It is characteristic of viral hepatitis that both levels are greatly increased, but the SGOT/SGPT ratio, normally greater than one, falls considerably below his figure. In a few cases of obstructive jaundice, the serum transaminase picture may initially resemble that in viral hepatitis, but the differential diagnosis can be established by repeating the determinations at intervals. Other enzyme tests, such as determination of alkaline phosphatase and leucylaminopeptidase, may be used to confirm the biliary obstruction. Flocculation tests and electrophoretic determination of the plasma protein picture, while of limited value in the diagnosis of acute viral hepatitis, are useful in conjunction with the serum transaminase test for assessing the activity of the disease and any tendency to progress towards “active” chronic hepatitis or post-hepatic cirrhosis.

Full text

PDF
69

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BANKS B. M., PINEDA E. P., GOLDBARG J. A., RUTENBURG A. M. Clinical value of serum leucine aminopeptidase determinations. N Engl J Med. 1960 Dec 22;263:1277–1281. doi: 10.1056/NEJM196012222632503. [DOI] [PubMed] [Google Scholar]
  2. BRUNS F., PULS W. Die Aktivität der Serumaldolase bei Erkrankungen der Leber; ein neuer enzymatischer Test. Klin Wochenschr. 1954 Jul 15;32(27-28):656–660. doi: 10.1007/BF01473835. [DOI] [PubMed] [Google Scholar]
  3. COLTORTI M., DISIMONE A., BARBIERI A. M., DELVECCHIOBLANCO C. VALUTAZIONE DI ALCUNI INDICI ENZIMATICI E DEL TEST DI JIRGL NELLA DIFFERENZIAZIONE TRA ITTERO EPATOCELLULARE E COLOSTATICO. I. CONFRONTI TRA I VARI INDICI. Policlinico Prat. 1963 Nov 11;70:1596–1604. [PubMed] [Google Scholar]
  4. DE RITIS F., COLTORTI M., GIUSTI G. An enzymic test for the diagnosis of viral hepatitis; the transaminase serum activities. Clin Chim Acta. 1957 Feb;2(1):70–74. doi: 10.1016/0009-8981(57)90027-x. [DOI] [PubMed] [Google Scholar]
  5. DE RITIS F., COLTORTI M., GIUSTI G. Attività transaminasiche del siero nell'epatite virale. Boll Soc Ital Biol Sper. 1955 May;31(5):394–396. [PubMed] [Google Scholar]
  6. DE RITIS F., GIUSTI G., COLTORTI M. Serum phosphoglucomutase activity in human virus hepatitis. Experientia. 1957 Feb 15;13(2):81–82. doi: 10.1007/BF02160104. [DOI] [PubMed] [Google Scholar]
  7. DE RITIS F., MALLUCCI L., COLTORTI M., GIUSTI G., CALDERA M. Anicteric virus hepatitis in a closed environment as shown by serum transaminase activity. Bull World Health Organ. 1959;20:589–602. [PMC free article] [PubMed] [Google Scholar]
  8. DELKESKAMP A., SCHMIDT E., SCHMIDT F. W. Fermentaktivitäts-Bestimmungen in der Diagnostik der anikterischen Hepatitis. Dtsch Med Wochenschr. 1959 Jan 30;84(5):188–190. doi: 10.1055/s-0028-1113568. [DOI] [PubMed] [Google Scholar]
  9. GIUSTI G. [Triosophosphate isomerase activity in the plasma in some conditions of human pathology (Viral hepatitis, progressive muscular dystrophy)]. Boll Soc Ital Biol Sper. 1962 Jan 15;38:10–11. [PubMed] [Google Scholar]
  10. GOLDBARG J. A., RUTENBURG A. M. The colorimetric determination of leucine aminopeptidase in urine and serum of normal subjects and patients with cancer and other diseases. Cancer. 1958 Mar-Apr;11(2):283–291. doi: 10.1002/1097-0142(195803/04)11:2<283::aid-cncr2820110209>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  11. JIRGL V. Ein Test zur Differentialdiagnose des Verschlussikterus. Klin Wochenschr. 1957 Sep 15;35(18):938–938. doi: 10.1007/BF01484281. [DOI] [PubMed] [Google Scholar]
  12. REICHARD H. Ornitincarbamyltransferas-bestámning i serum; ett nytt leverspecifikt prov. Nord Med. 1957 Jul 11;58(28):1016–1018. [PubMed] [Google Scholar]
  13. WOLF H. P., FORSTER G., LEUTHARDT F. Ein spezifischer optischer Fermenttest zum Nachweis von Parenchymschädigungen der Leber. Gastroenterologia. 1957;87(3-4):172–180. [PubMed] [Google Scholar]
  14. WOLFSON S. K., SPENCER J. A., STERKEI R. L., WILLIAMS-ASHMAN H. G. Clinical and experimental studies on serum pyridine nucleotide-linked dehydrogenases in liver damage. Ann N Y Acad Sci. 1958 Oct 13;75(1):260–269. doi: 10.1111/j.1749-6632.1958.tb36872.x. [DOI] [PubMed] [Google Scholar]
  15. YOUNG I. I. Serum 5-nucleotidase; characterization and evaluation in disease states. Ann N Y Acad Sci. 1958 Oct 13;75(1):357–362. doi: 10.1111/j.1749-6632.1958.tb36883.x. [DOI] [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES